Timothy Kidd Ph.D.


Dr Kidd is a National Health and Medical Research Council-funded Early Career Research Fellow who currently works in infectious diseases research at The University of Queensland. Tim completed his undergraduate studies at the Queensland University of Technology in 1992, and thereafter worked as a senior scientist within various clinical microbiology laboratories located in South-East Queensland, Australia. During this time Dr Kidd established the first Burkholderia species reference laboratory in Australia and developed high level expertise in the identification, characterisation, antimicrobial resistance and epidemiology of bacterial pathogens isolated from persons with cystic fibrosis (CF). In 2007 he commenced full-time research in CF microbiology, receiving his PhD at The University of Queensland in 2012. Since then he has worked in both clinical and basic science research fields at various research institutions in Australia and the UK. His current research interests focus on expanding the understanding of the acquisition, epidemiology, antimicrobial resistance and pathogenesis of acute and chronic Gram-negative bacterial infections. Dr Kidd's work in CF microbiology has been recognised internationally resulting in >50 peer-reviewed publications; with translation of his work extending to the development of revised international patient management guidelines and practices. Dr Kidd currently serves as an active member of the Antimicrobial Resistance International Working Group in Cystic Fibrosis, and the European Respiratory Society College of Experts. He also reviews manuscripts for many high impact scientific journals.